January 14, 2019 Intellectual Property and Tech Transactions Update
Client Newsletter
September 24, 2018 Intellectual Property and Tech Transactions Update
Client Newsletter
June 4, 2018 DOJ Announces Largest-Ever U.S. Antitrust Divestiture in the Bayer/Monsanto Transaction
Client Memorandum
April 26, 2018 Quarterly Report – Life Sciences Securities Litigation Activity in Q1 2018
Client Memorandum
March 28, 2018 Intellectual Property and Tech Transactions Update
Client Newsletter
January 23, 2018 Quarterly Report – Life Sciences Securities Litigation Activity in Q4 2017
Client Memorandum
December 18, 2017 Intellectual Property and Tech Transactions Update
Client Memorandum
October 18, 2017 Life Sciences Securities Litigation Activity in Q3 2017
Client Memorandum
July 19, 2017 Increased Activity and Emerging Patterns in Securities Litigation Against Life Sciences Companies
Client Memorandum
June 16, 2017 How Group Purchasing Organizations Reduce Healthcare Procurement Costs in a Highly Competitive Market

The Antitrust Source, June 2017

January 3, 2017 White Collar Update: Teva to Pay $519 Million in FCPA Resolution, a Pharmaceutical Industry Record
Client Memorandum
December 6, 2016 Addressing the Growing Threat of Securities Class Actions in the Life Sciences Sector
Client Memorandum
August 24, 2009 Davis Polk Antitrust Update
Client Newsflash
Resources Search: